- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03911024
Development and Piloting of a Just-in-Time, Personalized HIV Prevention Intervention for Youth Experiencing Homelessness and Unstable Housing
October 16, 2019 updated by: Diane Santa Maria, The University of Texas Health Science Center, Houston
Development and Piloting of a Just-in-Time, Personalized HIV Prevention Intervention for Youth Experiencing Homelessness (YEH) and Unstable Housing (Study Alias: HIV Prevention Messaging Intervention for YEH)
The purpose of this study is develop and pilot test a personalized HIV intervention with youth experiencing homelessness by creating and field testing prevention messages that address real-time predictors (e.g., sexual urge, use to use drugs, and substance use) of HIV risk behaviors,to evaluate the feasibility and acceptability of the intervention and to evaluate the intervention outcome effects on HIV risk behaviors (e.g., condomless sex, number of sexual partners, pre-exposure prophylaxis(PrEP) awareness, substance use during sex,Intravenous(IV)drug use)
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- English speaking
- HIV high risk: IV drug user or sexually active youth (sex in the past 3 months) who reports at least one of the following: condomless sex, concurrent sexual partners within 2 weeks,sex with a partner of unknown HIV status, or a bacterial STI in the last 6 months.
- Homelessness: staying on the streets or in a place not meant for human habitation, a shelter,hotel/motel, or some place they cannot stay for more than 30 days
Exclusion Criteria:
- Below 6th grade reading level:determined by the Rapid Estimate of Adult Literacy in Medicine Short Form (REALM)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: HIV
|
At the completion of each EMA, participants in the intervention group (n=50) will receive messages that address:1) unsafe sexual behaviors, 2) alcohol/drug use, 3) PrEP interest, and 4) HIV testing.
In addition, participants will have access to a button in the app that will link them to resources when/if they are the victim of sexual assault.
Finally, intervention arm youth will be asked to set a behavioral goal related to HIV prevention during this session.
Those goals will include increasing condom use, PrEP use, non-occupational post-exposure prophylaxis (nPEP) use, reducing number of sexual partners, not having sex with using drugs or drinking alcohol, avoiding IV drug use, getting testing for HIV, and testing and treating sexually transmitted infections (STIs) as needed
|
|
Placebo Comparator: General Health
|
Participants in the attention control condition (n=50) will answer the same EMA items as the Intervention group.
However, the intervention messages will contain content related to nutrition, physical activity, sleep hygiene, and tobacco use.
Finally, control arm youth will be asked to set a behavioral goal related to general health during this session.Those goals will include getting 7+ hours of sleep, eating >= 5 servings of fruits or vegetables, not using tobacco products, exercising at least 60 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility as assessed by number recruited
Time Frame: baseline
|
Number recruited is number of eligible youth minus number who refuse to participate.
|
baseline
|
|
Feasibility as assessed by number of participants who complete the study
Time Frame: 6 weeks
|
6 weeks
|
|
|
Feasibility as assessed by number of staff hours required
Time Frame: 6 weeks
|
6 weeks
|
|
|
Feasibility as assessed by number of participants who damage or lose phones
Time Frame: 6 weeks
|
6 weeks
|
|
|
Acceptability as assessed by score on the System Usability Scale (SUS)
Time Frame: 6 weeks
|
The System Usability Scale (SUS) consists of 10 items on a 5-point (0-4) Likert scale and is designed to assess acceptability of a product.
Overall score ranges from 0 to 100, with higher scores indicating greater acceptability.
|
6 weeks
|
|
Acceptability as assessed by score on the Mobile App Rating Scale (MARS)
Time Frame: 6 weeks
|
The Mobile App Rating Scale (MARS) consists of 23 items on a 5-point (1-5) scale is designed to score apps on the criteria of engagement, functionality, aesthetics, and information quality (sub-scales).
Total score is determined by calculating the mean of each sub-scale and an overall mean score.
High mean scores indicate a higher quality app.
|
6 weeks
|
|
Number of participants who complete greater than 80% of the Ecological Momentary Assessments (EMAs)
Time Frame: 6 weeks
|
6 weeks
|
|
|
Number of participants who read greater than 80% of Just-In-Time Adaptive Intervention (JITAI) messages
Time Frame: 6 weeks
|
6 weeks
|
|
|
Effect on HIV risk behaviors as assessed by number of participants who use condoms
Time Frame: 6 weeks
|
6 weeks
|
|
|
Effect on HIV risk as assessed by number who use substances before sex
Time Frame: 6 weeks
|
6 weeks
|
|
|
Effect on HIV risk as assessed by number of participants who have pre-exposure prophylaxis (PrEP) interest
Time Frame: 6 weeks
|
6 weeks
|
|
|
Effect on HIV risk as assessed by number of participants who undergo HIV or sexually transmitted infection (STI) testing
Time Frame: 6 weeks
|
6 weeks
|
|
|
Effect on HIV risk as assessed by number of sexual partners
Time Frame: 6 weeks
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 20, 2019
Primary Completion (Actual)
August 1, 2019
Study Completion (Actual)
August 1, 2019
Study Registration Dates
First Submitted
April 8, 2019
First Submitted That Met QC Criteria
April 8, 2019
First Posted (Actual)
April 10, 2019
Study Record Updates
Last Update Posted (Actual)
October 17, 2019
Last Update Submitted That Met QC Criteria
October 16, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HSC-SN-18-0501
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Behavior, Risk
-
Ohio State University Comprehensive Cancer CenterBreast Cancer Research FoundationRecruiting
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingBehavior, RiskUnited States
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedRisk ReductionSouth Africa
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompleted
-
Bournemouth UniversityDorset HealthCare University NHS Foundation TrustWithdrawnRisk Behavior | Violence | Risk Behavior, Health
-
University of California, San FranciscoUniversity of MiamiCompletedRisk ReductionUnited States
-
Hadassah Medical OrganizationCompletedHealth Behavior | Food Habits | Lifestyle Risk ReductionIsrael
-
Hadassah Medical OrganizationHebrew University of JerusalemNot yet recruitingHealth Behavior | Food Habits | Lifestyle Risk Reduction
-
Vivoptim SolutionsCompletedCardiovascular Risk | Lifestyle Risk Reduction | Cardiovascular Disease Prevention | Lifestyle (Sedentary Behavior and Physical Activity) | Health Behavior ChangeFrance
-
Istituto per la Ricerca e l'Innovazione BiomedicaFondazione Don Carlo Gnocchi Onlus; Universita degli Studi di Palermo; Medilink...RecruitingHealth Promotion | Life Style, Healthy | Risk ReductionItaly
Clinical Trials on HIV
-
Kaiser PermanenteUniversity of California, San DiegoCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
North Bronx Healthcare NetworkWithdrawnHIV | Chlamydia | GonorrheaUnited States
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
New York City Health and Hospitals CorporationCompletedHepatitis C | HIV/AIDS | Hiv | HCV Coinfection | HIV/AIDS and InfectionsUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)CompletedHIV InfectionsUnited States
-
Fundacion para la Investigacion Biomedica del Hospital...Instituto de Salud Carlos IIICompletedHIV Infection | HCV CoinfectionSpain
-
Emory UniversityNational Institutes of Health (NIH)Completed
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV InfectionsSouth Africa